Stay updated with breaking news from Mara Gordon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A cybersecurity company says it took down more than 250 websites selling fake versions of diabetes and weight-loss drugs like Ozempic in 2023. Health-care workers say it's growing problem tied to accessibly, affordability and stigma.
We break down what these drugs are, and how doctors are adapting their practices, while navigating weight stigma.
Ozempic and Mounjaro (used for diabetes), and Wegovy and Zepbound (approved for weight loss), are reshaping medicinal responses to obesity and weight loss.
GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?
In a world where people are constantly attempting to emulate celebrities, perhaps transparency is, indeed, necessary, especially when it comes to weight loss.